Recombinant Human Lysyl Oxidase Homolog 2/LOXL2(C-Avi-His)(Discontinued)

Source: Human cells.
MW :86.7kD.
Recombinant Human Lysyl Oxidase Homolog 2 is produced by our Mammalian expression system and the target gene encoding Gln26-Gln774 is expressed fused with a Avi-His tag at the C-terminus. Lysyl oxidase homolog 2 is a member of the lysyl oxidase gene family. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyses the first step in the formation of crosslinks in collagens and elastin. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. LOXL2 can also crosslink collagen type IV and hence influence the sprouting of new blood vessels. LOXL2 is an enzyme that is up-regulated in several types of cancer and is associated with a poorer prognosis. LOXL2 changes the structure of histones and thus changes the shape of the cells, making it easier for the cancer cells to metastasize.

Endotoxin : Less than 0.1 ng/µg (1 IEU/µg) as determined by LAL test.

For Research Use Only. Not for use in diagnostic/therapeutics procedures.

Subcellular location:	Secreted, Nucleus, Chromosome
Post transnational modification:	N-glycosylated. N-glycosylation on Asn-455 and Asn-644 may be essential for proper folding and secretion; may be composed of a fucosylated carbohydrates attached to a trimannose N-linked glycan core.
Tissue Specificity:	Expressed in many tissues. Highest expression in reproductive tissues, placenta, uterus and prostate. Up-regulated in a number of cancers cells and tissues.
BioGrid:	110201. 42 interactions.

There are currently no product reviews Write a review on this product!